“The lanolin paradox” and the safety of pharmaceutical-grade lanolin products are also discussed.
They suggested that if pharmaceutical companies limited the free alcohol content of lanolin in topical medicaments to 3% or less, the number of patients sensitized to lanolin would be greatly reduced.